Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Pharmafile

05:01 EDT 18th October 2018 | BioPortfolio

Here are the most relevant search results for "Pharmafile" found in our extensive news archives from over 250 global news sources.

More Information about Pharmafile on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Pharmafile for you to read. Along with our medical data and news we also list Pharmafile Clinical Trials, which are updated daily. BioPortfolio also has a large database of Pharmafile Companies for you to search.

Showing News Articles 1–25 of 1,000+ from Pharmafile

Wednesday 17th October 2018

-GSK cut 190 jobs in #Ulverston -NHS England approve Gilead's #Yescarta -#Trump signs trust-busting #biosimilar bill -FDA approves #HPVvaccine for 27-45 year olds Check out the Top Ten most popular articles on http://Pharmafile.com  last week! http:

-GSK cut 190 jobs in #Ulverston -NHS England approve Gilead's #Yescarta - #Trump signs trust-busting #biosimilar bill -FDA approves #HPVvaccine for 27-45 year olds

Samsung and Bioepis launch third Humira biosimilar in Europe http://bit.ly/2EsDayC  #pharma #humira #biosimilars .

Samsung and Bioepis launch third Humira biosimilar in Europe http://bit.ly/2EsDayC  #pharma #humira #biosimilars .

Prescription painkillers reclassified amid addiction concerns http://bit.ly/2Cn51NV  #UK #painkillers #policy

Prescription painkillers reclassified amid addiction concerns http://bit.ly/2Cn51NV  #UK #painkillers #policy

FDA approves Pfizer's Talzenna for breast cancer alongside tool to identify eligible patients: http://bit.ly/2RWTryh  @pfizer #breastcancer #cancer #pharma

FDA approves Pfizer's Talzenna for breast cancer alongside tool to identify eligible patients: http://bit.ly/2RWTryh  @pfizer #breastcancer #cancer #pharma

Roche signs $1 billion deal with cell therapy firm SQZ biotech http://bit.ly/2pUQ1zq  #Roche @SQZBiotech #Cancer #pharma .

Roche signs $1 billion deal with cell therapy firm SQZ biotech http://bit.ly/2pUQ1zq  #Roche @SQZBiotech #Cancer #pharma .

Samsung and Bioepis launch third Humira biosimilar in Europe: http://bit.ly/2EsDayC  #pharma #humira #biosimilars

Samsung and Bioepis launch third Humira biosimilar in Europe: http://bit.ly/2EsDayC  #pharma #humira #biosimilars

Roche signs $1 billion deal with cell therapy firm SQZ biotech: http://bit.ly/2pUQ1zq  #Roche @SQZBiotech #Cancer #pharma

Roche signs $1 billion deal with cell therapy firm SQZ biotech: http://bit.ly/2pUQ1zq  #Roche @SQZBiotech #Cancer #pha

Prescription painkillers reclassified amid addiction concerns http://bit.ly/2Cn51NV  #UK #painkillers

Prescription painkillers reclassified amid addiction concerns http://bit.ly/2Cn51NV  #UK #painkillers

Fewer patents being filed for novel infectious diseases and AMR diagnostic technologies; US leads, UK follows http://bit.ly/2AevHix  #research #antimicrobialresistance #innovation .

Fewer patents being filed for novel infectious diseases and AMR diagnostic technologies; US leads, UK follows http://bit.ly/2AevHix  #research #antimicrobialresistance #innovation .

Fewer patents being filed for novel infectious diseases and AMR diagnostic technologies; US leads, UK follows http://bit.ly/2AevHix  #research #antimicrobialresistance #innovationpic.twitter.com/BhJz3AMwrW

Fewer patents being filed for novel infectious diseases and AMR diagnostic technologies; US leads, UK follows http://bit.ly/2AevHix  #research #antimicrobialresistance #innovation pic.twitter.com/BhJz3AMwrW

FDA approves Pfizer's Talzenna for breast cancer alongside tool to identify eligible patients http://bit.ly/2RWTryh  @pfizer #breastcancer #cancer #pharma

FDA approves Pfizer's Talzenna for breast cancer alongside tool to identify eligible patients http://bit.ly/2RWTryh  @pfizer #breastcancer #cancer #pharma

Samsung and Bioepis launch third Humira biosimilar in Europe http://bit.ly/2EsDayC  #pharma #humira #biosimilarspic.twitter.com/miqhCKTsL3

Samsung and Bioepis launch third Humira biosimilar in Europe http://bit.ly/2EsDayC  #pharma #humira #biosimilars pic.twitter.com/miqhCKTsL3

Roche signs $1 billion deal with cell therapy firm SQZ biotech http://bit.ly/2pUQ1zq  #Roche @SQZBiotech #Cancer #pharmapic.twitter.com/zb4G1JPzpZ

Roche signs $1 billion deal with cell therapy firm SQZ biotech http://bit.ly/2pUQ1zq  #Roche @SQZBiotech #Cancer #pharma

Fewer patents being filed for novel infectious diseases and AMR diagnostic technologies; US leads, UK follows http://bit.ly/2AevHix  #research #antimicrobialresistance #innovation

Fewer patents being filed for novel infectious diseases and AMR diagnostic technologies; US leads, UK follows http://bit.ly/2AevHix  #research #antimicrobialresistance #innovation

FDA approves Pfizer's Talzenna for breast cancer alongside tool to identify eligible patients http://bit.ly/2RWTryh  @Pfizer #breastcancer #cancer #pharmapic.twitter.com/KJV7VGha5w

FDA approves Pfizer's Talzenna for breast cancer alongside tool to identify eligible patients http://bit.ly/2RWTryh  @Pfizer #breastcancer #cancer #pharma

Prescription painkillers reclassified amid addiction concerns http://bit.ly/2Cn51NV  #UK #painkillerspic.twitter.com/2Vo88egasK

Prescription painkillers reclassified amid addiction concerns http://bit.ly/2Cn51NV  #UK #painkillers pic.twitter.com/2Vo88egasK

Samsung and Bioepis launch third Humira biosimilar in Europe

Hot on the heels of Amgen, Samsung Bioepis and Biogen have announced the launch of their own biosimilar version of Abbvie’s best-selling drug Humira (adalimumab) in Europe. Like its reference product, it is authorised for use in a range of indications including rheumatoid and psoriatic arthritis, axial spondyloarthritis, psoriasis, Crohn’s disease, ulcerative colitis and uveitis, as well as Cr...

Roche signs $1 billion deal with cell therapy firm SQZ biotech

The Massachusetts-based cell therapy company SQZ Biotech, has announced the expansion of its collaboration with Swiss pharma giant Roche, in a deal that could be worth up to $1 billion. The collaboration is aimed at developing new treatments for cancer through the combination of SQZ’s cell therapy innovations and Roche’s expertise in the area of immunotherapy. read more

Fewer patents being filed for novel infectious diseases and AMR diagnostic technologies; US leads, UK follows

Fewer patents are being filed for point-of-care diagnostic technologies aimed at tackling infectious diseases and antimicrobial resistance (AMR), according to new research by intellectual property (IP) firms Marks & Clerk and CPA Global. The research highlights a downward trend in the number of patent filings on new technologies aimed at diagnosing infectious diseases and detecting pathogens a...

FDA approves Pfizer's Talzenna for breast cancer alongside tool to identify eligible patients

Pfizer’s Talzenna (talazoparib) has secured FDA approval, it has emerged. The poly (ADP-ribose) polymerase (PARP) inhibitor is now set to hit the market in the US in the treatment of deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), HER2‑negative locally advanced or metastatic breast cancer. The decision was based on study data derived from 431 participants with a known dele...

Prescription painkillers reclassified amid addiction concerns

Two commonly prescribed painkillers are set to be put under tighter controls in the United Kingdom after a number of deaths were linked to their use. The painkillers, pregabalin and gabapentin, are set to be reclassified as class C controlled substances amid concerns that the prescription only drugs were being abused. read more

Tuesday 16th October 2018

Roche's Kadcyla beats Herceptin breast cancer disease recurrence and death risk http://bit.ly/2QRIexW  @Roche #cancer

Roche's Kadcyla beats Herceptin breast cancer disease recurrence and death risk http://bit.ly/2QRIexW  @Roche #cancer

Amgen launches first biosimilar of best-selling Humira in Europe http://bit.ly/2pVPiOE  @Amgen #biosimilars #humirapic.twitter.com/8qYQmLL9C0

Amgen launches first biosimilar of best-selling Humira in Europe http://bit.ly/2pVPiOE  @Amgen #biosimilars #humira pic.twitter.com/8qYQmLL9C0

Trump administration propose ruling requiring price transparency on TV ads http://bit.ly/2Adw24U  #Trump #drugpricingpic.twitter.com/TAi54ILMa5

Trump administration propose ruling requiring price transparency on TV ads http://bit.ly/2Adw24U  #Trump #drugpricing pic.twitter.com/TAi54ILMa5

Novartis and Bayer seek to oppose High Court ruling over NHS decision to use cheaper drug http://bit.ly/2CgLnmR  #Novartis #Bayer #NHSpic.twitter.com/vqGC0FBlEq

Novartis and Bayer seek to oppose High Court ruling over NHS decision to use cheaper drug http://bit.ly/2CgLnmR  #Novartis #Bayer #NHS pic.twitter.com/vqGC0FBlEq


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks